Results of NGS analysis from primary tumor of the patient

GenesAmino Acid ChangeAllele Ratio
ATMap.Asp1853AsnG = 0.57, A = 0.43
BRCA1p.Asn1052AspT = 0.8421, C = 0.1579
BAP1p.Arg114CysG = 0.8783, A = 0.1217
TSC1p.Lys106ArgT = 0.8925, C = 0.1075
TP53ap.Ala159ProCGCGGACGCGGGT = 0.7869, GGCGGACGCGGGT = 0.2131
MIR4673,NOTCH1ap.Gly347AspC = 0.7327, T = 0.2673
CDH1p.Val556LeuG = 0.9169, T = 0.0831
TP53p.Gly266TerC = 0.9294, A = 0.0706, G = 0.0, T = 0.0
CDKN2Ap.Ser7fsTC = 0.7684, T = 0.2, TT = 0.0316
MSH2p.Ser734PheC = 0.9257, T = 0.0743
PTCH1p.Gly1299AspC = 0.9205, T = 0.0795

atumor-associated mutations with highest frequency